Kabra Drugs Ltd — Board Meeting, 18-06-2025: Board Meeting

Kabra Drugs Limited has announced a board meeting that approved the acquisition of AMR Pharma India Pvt Ltd and plans to strategize the acquisition of Bonn Schtering Bio Sciences in Pondicherry. The company received FDA approval for manufacturing and selling from its Chennai facility, enhancing its production capabilities. The board decided to establish a subsidiary focused on AI and Machine Learning applications in pharmaceuticals, clinical research, diagnostics, e-pharmacy, and medical tourism, signaling a diversification into tech-driven healthcare services. Expansion of sales through senior state and district-level channel partners across India was also authorized, aiming to boost its own medicine brand presence nationwide.